Filing Details

Accession Number:
0001104659-14-068636
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-26 18:45:17
Reporting Period:
2014-09-24
Filing Date:
2014-09-26
Accepted Time:
2014-09-26 18:45:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550424 Mark Rothera C/O Ptc Therapeutics, Inc.,
100 Corporate Court
South Plainfield NJ 07080
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-24 900 $10.85 17,900 No 4 M Direct
Common Stock Disposition 2014-09-24 900 $43.86 17,000 No 4 S Direct
Common Stock Disposition 2014-09-24 2,000 $42.88 15,000 No 4 S Direct
Common Stock Acquisiton 2014-09-25 4,099 $10.85 19,099 No 4 M Direct
Common Stock Acquisiton 2014-09-25 3,001 $10.85 22,100 No 4 M Direct
Common Stock Disposition 2014-09-25 7,100 $44.15 15,000 No 4 S Direct
Common Stock Disposition 2014-09-25 3,000 $44.92 12,000 No 4 S Direct
Common Stock Disposition 2014-09-26 3,000 $46.90 9,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2014-09-24 900 $0.00 900 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2014-09-25 4,099 $0.00 4,099 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2014-09-25 3,001 $0.00 3,001 $10.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,100 2023-05-15 No 4 M Direct
10,001 2023-05-15 No 4 M Direct
146,999 2023-05-15 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 21, 2013, as amended on March 17, 2014 and August 12, 2014.
  2. This option was granted on May 15, 2013. 25% of the grant vested on December 31, 2013. The remainder vests as to 1/48 of the shares underlying such option each month until December 2016.
  3. This option was granted on May 15, 2013. 25% of the grant vested on May 15, 2014. The remainder vests as to 1/48 of the shares underlying such option each month until May 2017.
  4. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.85 to $43.89 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $42.85 to $42.94 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.85 to $44.38 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  7. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $44.85 to $45.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  8. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.85 to $46.93 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.